Moomoo AI 已提取核心信息
On February 7, 2024, Panbela Therapeutics, Inc. reported to the SEC that its Compensation Committee approved retention bonuses for employees, including CEO Jennifer K. Simpson and CFO Susan Horvath. The bonuses are contingent on employment through August 15, 2024, or until a change in control of the company occurs. Simpson and Horvath are set to receive $54,281 and $34,299 respectively. Additionally, the Committee certified the cash incentive compensation for fiscal year 2023, with Horvath receiving $119,394. Despite being eligible for $227,084, Simpson waived her cash incentive for 2023. The retention agreement details were filed with the SEC and are incorporated into the report.
On February 7, 2024, Panbela Therapeutics, Inc. reported to the SEC that its Compensation Committee approved retention bonuses for employees, including CEO Jennifer K. Simpson and CFO Susan Horvath. The bonuses are contingent on employment through August 15, 2024, or until a change in control of the company occurs. Simpson and Horvath are set to receive $54,281 and $34,299 respectively. Additionally, the Committee certified the cash incentive compensation for fiscal year 2023, with Horvath receiving $119,394. Despite being eligible for $227,084, Simpson waived her cash incentive for 2023. The retention agreement details were filed with the SEC and are incorporated into the report.
2024年2月7日，Panbela Therapeutics, Inc.向美国证券交易委员会报告说，其薪酬委员会批准了向包括首席执行官詹妮弗·辛普森和首席财务官苏珊·霍瓦斯在内的员工发放留用奖金。奖金取决于2024年8月15日之前的就业情况，或者直到公司控制权发生变化为止。辛普森和霍瓦斯将分别获得54,281美元和34,299美元。此外，委员会还认证了2023财年的现金激励薪酬，霍瓦斯获得了119,394美元。尽管有资格获得227,084美元，但辛普森还是放弃了2023年的现金激励。保留协议的详细信息已提交给美国证券交易委员会，并已纳入报告中。
2024年2月7日，Panbela Therapeutics, Inc.向美国证券交易委员会报告说，其薪酬委员会批准了向包括首席执行官詹妮弗·辛普森和首席财务官苏珊·霍瓦斯在内的员工发放留用奖金。奖金取决于2024年8月15日之前的就业情况，或者直到公司控制权发生变化为止。辛普森和霍瓦斯将分别获得54,281美元和34,299美元。此外，委员会还认证了2023财年的现金激励薪酬，霍瓦斯获得了119,394美元。尽管有资格获得227,084美元，但辛普森还是放弃了2023年的现金激励。保留协议的详细信息已提交给美国证券交易委员会，并已纳入报告中。
有用
没用